id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-1828-0009,FDA,FDA-2019-D-1828,E19 A SELECTIVE APPROACH TO SAFETY DATA COLLECTION IN SPECIFIC LATE-STAGE PREAPPROVAL OR POST-APPROVAL CLINICAL TRIALS,Other,Guidance,2022-12-06T05:00:00Z,2022,12,2022-12-06T05:00:00Z,,2025-07-24T09:00:23Z,,1,0,090000648551c1c7
FDA-2019-D-1828-0008,FDA,FDA-2019-D-1828,E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-Approval or Post-Approval Clinical Trials; International Council for Harmonisation; Guidance for Industry; Availability,Notice,Notice of Availability,2022-12-06T05:00:00Z,2022,12,2022-12-06T05:00:00Z,,2022-12-06T13:19:55Z,2022-26433,0,0,090000648551e24f